Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
Level 5 - mechanism / opinion, no new human data
Narrative review and in vitro mechanistic research without clinical data
PubMed 10961432 · doi:10.1007/978-3-7091-6781-6_22
What was done
This narrative review synthesized mechanistic findings on how hyperphosphorylation of tau protein leads to microtubule disruption and neurofibrillary tangle formation in Alzheimer disease and other tauopathies, summarizing in vitro studies of tau dephosphorylation by protein phosphatases PP-2A, PP-2B, and PP-1.
What was found
No quantitative data, sample sizes, or effect estimates were reported in the abstract. Qualitatively, hyperphosphorylated tau disrupted microtubules by sequestering normal tau, MAP1, and MAP2, and formed filament tangles when associating with normal tau. In vitro dephosphorylation of hyperphosphorylated tau by PP-2A, PP-2B, and to a lesser extent PP-1 restored microtubule assembly activity, and PP-2A treatment dissociated isolated paired helical filaments into functional tau.
Why it matters
It outlines the biochemical rationale that restoring or enhancing tau phosphatase activity could counteract microtubule breakdown and neurofibrillary degeneration in Alzheimer disease.
Limits
The abstract reports purely preclinical and in vitro biochemical observations without quantitative metrics, sample sizes, or in vivo human clinical data.
Cited by
- supports Tau hyperphosphorylation causes tau to dissociate from microtubules, leading to structural microtubule and synaptic collapse.